"A peer-reviewed study based on a massive British database
has linked long-term use of oral bisphosphonate drugs to a higher risk
of esophageal cancer, contrary to a separate study of the same database
released a few weeks ago that found no evidence of increased risk. The
competing conclusions have reopened the debate about a class-wide cancer
risk, and a label change for the popular osteoporosis agents could be
on the table..." cont'd
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.